Capstone Investment Advisors »

Catalyst Pharmaceutical Partners shares owned by Capstone Investment Advisors

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by Capstone Investment Advisors from 13F filings

Historical chart of Capstone Investment Advisors investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by Capstone Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by Capstone Investment Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $708k 36k 19.88
2024-03-31 $361k 23k 15.94

More positions owned by Capstone Investment Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
NVIDIA Corporation Put Option (NVDA)
Apple Put Option (AAPL)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Microsoft Corporation Put Option (MSFT)
Meta Platforms Cl A (META)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
Amazon Call Option (AMZN)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Alphabet Cap Stk Cl A (GOOGL)
Tesla Motors Call Option (TSLA)
Alphabet Cap Stk Cl C Call Option (GOOG)
Broadcom (AVGO)
Vaneck Etf Trust Gold Miners Etf Call Option (GDX)

View all positions for Capstone Investment Advisors

Top funds holding Catalyst Pharmaceutical Partners

BlackRock
Vanguard Group
Deerfield Management Company
State Street Corporation
Dimensional Fund Advisors
Pacer Advisors
Geode Capital Management
Renaissance Technologies
First Trust Advisors
Royce & Associates
Goldman Sachs Group
Northern Trust
Robeco Investment Management
T. Rowe Price Associates
Charles Schwab Investment Management

View all funds holding Catalyst Pharmaceutical Partners